Guanfacine is a prescription medication with two primary uses: treating ADHD and lowering high blood pressure. It comes in two formulations, each designed for a different purpose. The extended-release version (brand name Intuniv) is FDA-approved specifically for ADHD in children and adolescents, while the immediate-release tablet has been used for decades to manage hypertension in adults.
ADHD Treatment
The extended-release form of guanfacine is approved as both a standalone treatment and an add-on to stimulant medications for ADHD. It works differently from stimulants like methylphenidate or amphetamine. Instead of increasing dopamine activity, guanfacine targets a specific type of receptor in the prefrontal cortex, the part of the brain responsible for attention, impulse control, and working memory. By strengthening the connections between neurons in this region, it helps the brain maintain focus, especially in distracting environments.
In a Phase III clinical trial of children and adolescents ages 6 to 17, guanfacine produced a significant reduction in ADHD symptoms. Patients on guanfacine showed an 8.9-point greater improvement on a standard ADHD rating scale compared to placebo, and nearly 24% more patients were rated as “very much improved” or “much improved” by their clinicians. The medication also improved functioning at school and within the family, based on parent-reported measures.
Guanfacine is particularly useful for people who can’t tolerate stimulants or who need something in addition to a stimulant. A controlled trial comparing guanfacine alone, a stimulant alone, and the two combined found that the combination produced consistently greater reductions in inattentive symptoms than either medication by itself. The combination was well tolerated, with no serious cardiovascular events. Sedation and fatigue were more common in patients taking guanfacine, whether alone or combined, but side effects were generally mild to moderate.
Blood Pressure Management
The immediate-release form of guanfacine is prescribed for high blood pressure in adults. It’s typically taken at bedtime, starting at 1 mg per day, with the dose gradually increased up to 3 mg if needed. The bedtime dosing is intentional: guanfacine lowers blood pressure partly by reducing activity in the sympathetic nervous system, and drowsiness is a common effect. Taking it at night lets you sleep through the peak sedation.
Off-Label Use for Tic Disorders
Guanfacine has shown benefit for children who have both ADHD and tic disorders, a combination that creates a tricky treatment challenge because stimulants can sometimes worsen tics. In a Yale study of 34 children with both conditions, guanfacine improved ADHD symptoms by 37% on a standard rating scale (compared to 8% for placebo) while also reducing tics and improving attention and impulse control on cognitive tests. This makes it a valuable option when stimulants aren’t appropriate.
How It Feels: Common Side Effects
The most frequently reported side effects are drowsiness, fatigue, and low energy, particularly during the first few weeks or after a dose increase. These tend to improve over time as your body adjusts. Guanfacine also lowers heart rate and blood pressure, which is the intended effect when used for hypertension but an unwanted side effect for some ADHD patients. Dizziness, especially when standing up quickly, can occur for this reason.
Because guanfacine affects blood pressure, you should not stop taking it abruptly. Sudden discontinuation can cause rebound hypertension, where blood pressure spikes above pre-treatment levels, sometimes severely. Children may be at particular risk for this because gastrointestinal illnesses that cause vomiting can unexpectedly prevent them from keeping the medication down. The recommended approach for stopping guanfacine is to taper the dose by no more than 1 mg every 3 to 7 days.
How Dosing Works for ADHD
For ADHD, the extended-release tablet is started at 1 mg per day and increased by no more than 1 mg per week. The effective range is 1 to 4 mg daily for most patients, though adolescents ages 13 to 17 may take up to 7 mg in some cases. The slow titration schedule exists to minimize sedation and blood pressure changes. Unlike stimulants, which often produce noticeable effects within hours, guanfacine typically requires several weeks of dose adjustment before you’ll see its full benefit.
If you’re switching from immediate-release guanfacine to the extended-release version, the two aren’t interchangeable at the same dose. The switch involves stopping the immediate-release form and starting a fresh titration with the extended-release tablet.
How Guanfacine Compares to Stimulants
Stimulants remain the first-line treatment for ADHD because they tend to produce larger symptom reductions. Guanfacine is generally considered a second-line option or an add-on. Its advantages are that it’s not a controlled substance, it doesn’t carry the same risk of appetite suppression or insomnia, and it can be especially helpful for hyperactivity and emotional regulation. Some clinicians prefer it for younger children or for patients whose anxiety or agitation worsens on stimulants.
The combination approach is worth knowing about. When guanfacine was paired with a stimulant in a head-to-head trial, the combination outperformed either drug alone for inattentive symptoms and overall clinical improvement. This suggests the two medications work through complementary brain pathways, with stimulants boosting dopamine signaling and guanfacine strengthening prefrontal cortex connections through a different mechanism.